CVS Health Corporation(CVS) Stock Research - Grey Stern Research

CVS Health Corporation (CVS) Stock Analysis

$62.92 (1.09%)

CVS Financial Performance


Use the table below to view CVS Health Corporation's financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q2 - 2024

Metric Value Ranking among Peers
Price $62.24 -
52 Week Low $52.77 -
52 Week High $83.25 -
Market Cap $78.3 Billion 3/7
Gross Margin 15% 7/7
Profit Margin 2% 5/7
EBITDA margin 5% 1/7
Q2 - 2024 Revenue $91.3 Billion 2/7
Q2 - 2024 Earnings $1.8 Billion 2/7
Q2 - 2024 Free Cash Flow $2.5 Billion 2/7
Trailing 4 Quarters Revenue $363.3 Billion 2/7
Trailing 4 Quarters Earnings $7.2 Billion 2/7
Quarterly Earnings Growth -7% 5/7
Annual Earnings Growth -13% 2/7
Quarterly Revenue Growth 3% 7/7
Annual Revenue Growth 5% 4/7
Cash On Hand $12.6 Billion 3/7
Short Term Debt $5.6 Billion 2/7
Long Term Debt $62.6 Billion 2/7

CVS Health Corporation Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare CVS Health Corporation's metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 10.89 6/7
PS 0.22 7/7
PB 1.04 7/7
PC 6.23 4/7
Liabilities to Equity 2.37 3/7
ROA 0.03 3/7
ROE 0.10 2/7
Current Ratio 1.42 5/7
Quick Ratio 0.09 6/7
Long Term Debt to Equity 0.84 2/7
Debt to Equity 1.12 2/7
Burn Rate 5.85 5/7
Cash to Cap 0.16 4/7
CCR 1.38 3/7
EV to EBITDA 34.08 4/7
EV to Revenue 0.41 5/7

Company Details

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

CEO: Mr. Larry Merlo

Website: https://www.cvshealth.com

Address: 1 Cvs Dr Woonsocket, RHODE ISLAND

Exchange: New York Stock Exchange

Industry: Healthcare Plans

CVS Health Corporation Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to CVS Health Corporation. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
UnitedHealth Group Incorporated UNH $546.9 Billion
Centene Corporation CNC $38.2 Billion
Cigna Corporation CI $95.2 Billion
Humana Inc. HUM $29.7 Billion
Molina Healthcare, Inc. MOH $19.4 Billion
Alignment Healthcare, Inc. ALHC $2.2 Billion
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
CVS Income Statements
Quarter Year Revenue Earnings
Q2 2024 $ 91.3 Billion $1.8 Billion
Q1 2024 $ 88.4 Billion $1.1 Billion
Q4 2023 $ 93.8 Billion $2.0 Billion
Q3 2023 $ 89.8 Billion $2.3 Billion
Q2 2023 $ 88.9 Billion $1.9 Billion
Q1 2023 $ 85.3 Billion $2.1 Billion
Q4 2022 $ 83.8 Billion $2.3 Billion
Q3 2022 $ 81.2 Billion -$3.4 Billion

View All

CVS Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q2 2024 $12.6 Billion $252.5 Billion $83.8 Billion $75.1 Billion
Q1 2024 $9.8 Billion $249.7 Billion $81.8 Billion $74.2 Billion
Q4 2023 $8.2 Billion $249.7 Billion $74.9 Billion $76.6 Billion
Q3 2023 $13.0 Billion $251.3 Billion $80.1 Billion $74.5 Billion
Q2 2023 $13.8 Billion $250.1 Billion $79.0 Billion $72.7 Billion
Q1 2023 $14.6 Billion $239.3 Billion $76.5 Billion $71.4 Billion
Q4 2022 $12.9 Billion $228.3 Billion $70.7 Billion $71.0 Billion
Q3 2022 $17.2 Billion $231.2 Billion $71.1 Billion $71.0 Billion

View All

CVS Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q2 2024 $2.5 Billion -$638.0 Million $2.7 Billion
Q1 2024 $4.2 Billion -$705.0 Million $1.6 Billion
Q4 2023 -$3.5 Billion -$911.0 Million -$4.9 Billion
Q3 2023 $2.2 Billion -$545.0 Million -$752.0 Million
Q2 2023 $5.3 Billion -$591.0 Million -$828.0 Million
Q1 2023 $6.5 Billion -$984.0 Million $1.7 Billion
Q4 2022 -$2.6 Billion -$688.0 Million -$4.3 Billion
Q3 2022 $8.5 Billion -$580.0 Million $5.1 Billion

View All

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions